Nifty Pharma News, Corporate filings and Earnings/Conference Calls

Keep track of all breaking news and updates on Nifty Pharma from all sources in a single place.

Load latest

Sun Pharmaceutical Industries Ltd.

16 May 2025

1739.60

0.27%

Sun Pharma gets USFDA approval for new device to treat skin disease

Business Standard

The company says that the new device is more compact and easier to use than its predecessor

Number of FII/FPI investors increased from 1310 to 1351 in Mar 2025 qtr.

Alkem Laboratories Ltd.

16 May 2025

5391.50

3.27%

Alkem reports cyber security incident at Enzene's US subsidiary

Business Line

The incident resulted in a fraudulent transfer of funds

Number of FII/FPI investors increased from 524 to 535 in Mar 2025 qtr.

Aurobindo Pharma Ltd.

16 May 2025

1212.50

0.94%

Board Meeting

Aurobindo Pharma Ltd - 524804 - Board Meeting Intimation for Intimation Of Board Meeting.

BSE India

Aurobindo Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/05/2025 ,inter alia, to consider and approve Intimation of Board meeting to be held on May 26, 2025 to consider Audited Financial Results for the fourth quarter and financial year ended March 31, 2025.

pdf

Sun Pharmaceutical Industries Ltd.

16 May 2025

1739.60

0.27%

Company Update

Sun Pharmaceutical Industries Ltd - 524715 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

BSE India

Intimation of Press Release

pdf

Aurobindo Pharma Ltd.

16 May 2025

1212.50

0.94%

Aurobindo Pharma's arm teams up with IMT Hyderabad for leadership development

Business Line

This program is an important step in grooming our middle managers to take on larger responsibilities with confidence and agility,' Vice President, Corporate HR, Aurobindo Pharma

Promoters unpledged 0.91% of shares in last quarter. Total pledge stands at 16.92% of promoter holdings

Zydus Lifesciences Ltd.

16 May 2025

913.95

1.25%

Company Update

Zydus Lifesciences Ltd - 532321 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

Newspaper publication of notice of loss of share certificates of the company published in the Financial Express English and Gujarati editions, both on May 16, 2025.

pdf

Cipla Ltd.

16 May 2025

1492.00

-0.53%

Earnings Call

Cipla Ltd - 500087 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

BSE India

We are enclosing herewith copy of the transcript of the Company''s Q4 FY25 earning conference call dated 13th May 2025

pdf

Abbott India Ltd.

16 May 2025

30600.00

0.13%

Company Update

Abbott India Ltd - 500488 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

Newspaper Publication of Audited Financial Results of the Company for the quarter and year ended on March 31, 2025.

pdf

Lupin Ltd.

16 May 2025

2047.20

-1.02%

Company Update

Lupin Ltd - 500257 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

Copy of Newspaper Publication in respect of Audited Financial Results of the Company for the quarter and year ended March 31, 2025.

pdf

Alkem Laboratories Ltd.

16 May 2025

5391.50

3.27%

Board Meeting

Alkem Laboratories Ltd - 539523 - Board Meeting Intimation for Notice Of Meeting Of Board Of …

BSE India

Alkem Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2025 ,inter alia, to consider and approve (i) the Standalone and Consolidated Audited Financial Results of the Company for the quarter and financial year ended 31st March, 2025; and (ii) to consider and recommend Final Dividend, if any, for financial year ended 31st March, 2025. Kindly take note of the same.

pdf

Is Nifty Pharma worth buying?

310 Votes:

Buy 79.35%

Sell 11.61%

Hold 9.03%

Nifty Pharma PB	5.3
Nifty Pharma PE	32.2
Nifty Pharma DIV	0.6
Nifty Pharma EPS	671